GARNET: high SVR rates following eight-week treatment with ombitasvir/paritaprevir/ritonavir + dasabuvir for patients with HCV genotype 1b infection [abstract 163]
Journal
New Perspectives in Hepatitis C Virus Infection – The Roadmap for Cure, September 23-24, 2016
